CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Strata Critical Medical Publishes Q3 2026 Earnings Call Transcript

By Public Technologies
  • Strata Critical Medical’s Nov. 3, 2026, third-quarter earnings call featured co-CEOs Will Heyburn and Melissa Tomkiel, alongside finance executive Mat Schneider.
  • Management announced a $20 million share repurchase authorization, citing an attractive stock valuation.
  • Revenue rose 50.3% to $74.1 million; adjusted EBITDA increased to $9.6 million from $4.2 million a year earlier.
  • Full-year 2026 guidance remained unchanged: revenue of $285 million–$295 million, adjusted EBITDA of $33 million–$35 million.
  • Management expects Clinical to lead 2027 growth, targeting high-teens organic adjusted EBITDA growth and more than 30% growth including acquisitions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Strata Critical Medical Inc. published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk